US Patent 11135226 Use of reboxetine to treat narcolepsy
Patent 11135226 was granted and assigned to Axsome Therapeutics on October, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+539 characters)
Article
Patent abstract
Described herein are methods of treating narcolepsy with cataplexy, comprising administering reboxetine (including esreboxetine) to a human being in need thereof. Reboxetine (including esreboxetine) may also be used in the manufacture of a medicament for the treatment of narcolepsy with cataplexy. Also disclosed herein are kits comprising a pharmaceutical composition comprising reboxetine (including esreboxetine) and instructions to use the pharmaceutical composition to treat narcolepsy with cataplexy in a human being.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Herriot Tabuteau0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111352260
Date of Patent
October 5, 2021
0Patent Application Number
202102170
Date Filed
February 17, 2021
0Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 22 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 6 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11135226 Use of reboxetine to treat narcolepsy
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11135226
Date of patent
October 5, 2021
Patent application number
20210217
Date Filed
February 17, 2021
Find more entities like US Patent 11135226 Use of reboxetine to treat narcolepsy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
